Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Mar 15;62(6):961-962.
doi: 10.2169/internalmedicine.0385-22. Epub 2022 Aug 10.

Response to Letter to the Editor: "Clinical Implication of an Elevated Circulating Galectin-3 Level on Predicting the Occurrence of Ventricular Arrhythmias"

Hisaki Makimoto  1 , Tina Lin  2 , Alexandru Bejinariu  1
Affiliations
Comment

Response to Letter to the Editor: "Clinical Implication of an Elevated Circulating Galectin-3 Level on Predicting the Occurrence of Ventricular Arrhythmias"

Hisaki Makimoto et al. Intern Med. .
No abstract available

Keywords: galectin-3; heart failure; ventricular arrhythmias.

PubMed Disclaimer

Conflict of interest statement

The authors state that they have no Conflict of Interest (COI).

Figures

Figure.
Figure.
Time-dependent receiver operating characteristic (ROC) curves for galectin-3 and appropriate ICD therapy. The ROC curves at 381, 510 and 551 days of follow-up (1st, 2nd and 3rd quartile of follow-up) are shown.
See this image and copyright information in PMC

Comment on

References

    1. Nakagawa Y, Kataoka N, Imamura T. Clinical implication of elevated circulating galectin-3 level on predicting the occurrence of ventricular arrhythmias. Intern Med 62: 959, 2023. - PMC - PubMed
    1. Chow SL, Maisel AS, Anand I, et al. Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American Heart Association. Circulation 135: e1054-e1091, 2017. - PubMed
    1. Stolen CM, Adourian A, Meyer TE, et al. Plasma galectin-3 and heart failure outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy). J Card Fail 20: 793-799, 2014. - PubMed
    1. Makimoto H, Müller P, Denise K, et al. Clinical impact of circulating galectin-3 on ventricular arrhythmias and heart failure hospitalization independent of prior ventricular arrhythmic events in patients with implantable cardioverter-defibrillators. Intern Med 61: 969-977, 2022. - PMC - PubMed
    1. Elsokkari I, Parkash R, Tang A, et al. Mortality risk increases with clustered ventricular arrhythmias in patients with implantable cardioverter-defibrillators. JACC Clin Electrophysiol 6: 327-337, 2020. - PubMed